Brean Murray raised their price target on Dendreon Corp. (Nasdaq: DNDN) from $50 to $65 following approval of Provenge ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE